MassMutual Private Wealth & Trust’s Definium Therapeutics DFTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.1K	Sell	448 -120	-21%	-$5.06K	﹤0.01%	1131
2026 Q2	$26.7K	Hold	568	–	–	﹤0.01%	1018
2026 Q1	$10.7K	Hold	568	–	–	﹤0.01%	1340
2025 Q4	$7.61K	Buy	568 +136	+31%	+$1.68K	﹤0.01%	1502
2025 Q3	$5.09K	Hold	432	–	–	﹤0.01%	1667
2025 Q2	$2.8K	Sell	432 -135	-24%	-$888	﹤0.01%	1848
2025 Q1	$3.32K	Buy	+567	New	+$4.06K	﹤0.01%	1755

Other funds holding DFTX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

MassMutual Private Wealth & Trust's DFTX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Definium Therapeutics (DFTX) stake by 21% in Q3 2026, selling an estimated $5.06K and leaving 448 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

MassMutual Private Wealth & Trust first reported a position in DFTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $26.7K in Q2 2026. 127 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

MassMutual Private Wealth & Trust held 448 shares of Definium Therapeutics worth $17.1K as of Q3 2026.
MassMutual Private Wealth & Trust sold 120 Definium Therapeutics shares in Q3 2026, an estimated $5.06K.
Definium Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1131 holding.
MassMutual Private Wealth & Trust first reported a position in Definium Therapeutics in Q1 2025 and has held it in 7 quarters since.
MassMutual Private Wealth & Trust's Definium Therapeutics position peaked at $26.7K in Q2 2026.
127 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.